When pembrolizumab was added to paclitaxel with or without bevacizumab in platinum-resistant ovarian cancer, significant ...
The U.S. Supreme Court declined on Monday to hear a bid by a group of physicians and healthcare providers to revive their ...
Among patients with late diagnosed HIV infection, the choice of a two- or three-drug regimen is not associated with 48 week ...
CNW/ - Dalhousie University, in collaboration with Nova Scotia Health's INSPIRED COPD Outreach Program, the Nova Scotia ...
GlaxoSmithKline ( ($GB:GSK) ) has shared an announcement. GSK and Spero Therapeutics announced promising results from the phase III PIVOT-PO trial ...
TipRanks on MSN
GSK’s Shingrix Prefilled Syringe Gains Positive CHMP Opinion
GlaxoSmithKline ( ($GB:GSK) ) has issued an announcement. GSK announced that the European Medicine Agency’s Committee for Medicinal Products for ...
Data presented at IDWeek 2025 after study stopped early for efficacyPrimary endpoint met, demonstrating non-inferiority of ...
The Telegraph on MSN
Madison County approves up to $300,000 in vaccines for Health Department clinic
Madison County Health Clinic expands vaccine access for children and adults ...
The Rt Hon Yvette Cooper, Secretary of State for Foreign, Commonwealth and Development Affairs, calls for continued support to tackle AIDS ...
Liposarcoma market growth is driven by increasing awareness and earlier diagnosis, expanding the pool of treatable patients. Advances in molecular profiling and targeted therapies ...
GSK and Spero Therapeutics' oral cabapenem, tebipenem HBr, has become the first antibiotic in the class to show efficacy in a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback